Evidence map›Paper›PMID 33085971›Full record

ArticleJournal of Crohn's & colitis2020

International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.

Sara Lewin, Charles Lees, Miguel Regueiro, Ailsa Hart, Uma Mahadevan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Exploring the Experiences of Virtual Inflammatory Bowel Disease Care in Saskatchewan.The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres · 2024
    Article
  4. Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  5. Article
  6. Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study.Journal of the Formosan Medical Association = Taiwan yi zhi · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Sara LewinDivision of Gastroenterology, University of California, San Francisco, CA, USA.
Charles LeesInstitute of Genetics & Molecular Medicine, University of Edinburgh, Edinburgh, UK.
Miguel RegueiroDepartment of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic, Cleveland, OH, USA.
Ailsa HartIBD Unit, St Mark's Hospital, London, UK.
Uma MahadevanDivision of Gastroenterology, University of California, San Francisco, CA, USA.
University of California, San Francisco · USCleveland Clinic · USMRC Institute of Genetics and Molecular Medicine · GBSt Mark's Hospital · GB

Funding

Medical Research Council MR/S034919/1
6 · The paper itself

Abstract

Before the onset of the COVID-19 pandemic, the majority of care for inflammatory bowel disease patients was provided in-person. The practice of gastroenterology care has since rapidly transformed, with telemedicine emerging as an essential tool to provide medical care to patients while maintaining social distancing and conserving personal protective equipment. This article provides insight into past and current practices among inflammatory bowel disease specialists and shares regulatory, financial and practical considerations for incorporating telemedicine into clinical practice. Continued government and other payer support for telemedicine and ongoing innovation to provide remote objective patient data will help to sustain the use of telemedicine long after the current pandemic subsides.

Indexed as

BetacoronavirusCoronavirus InfectionsCOVID-19GastroenterologyGlobal HealthHumansInflammatory Bowel DiseasesPandemicsPneumonia, ViralPractice Patterns, Physicians'SARS-CoV-2TelemedicineCOVID-19inflammatory bowel diseasereimbursementTelemedicine

Identifiers

PMID33085971
PMCPMC7665391
OpenAlexW3094337111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.